SMMT and GSK Related Headlines

Go Back

Jan 12, 2026 06:15AM Summit Therapeutics partners with GSK for cancer drug combination trial
Jan 12, 2026 06:15AM Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)

SMMT and GSK Related Press Releases

Go Back

Jan 12, 2026 06:15AM Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)

SMMT and GSK Related SEC Filings

Go Back